AI assistant
Sending…
Entera Bio Ltd. — Director's Dealing 2024
Jan 16, 2024
35604_dirs_2024-01-16_4d90e156-4278-439c-bd47-799d83777ccf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2024-01-12
Reporting Person: Taitel Haya (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-12 | Ordinary Shares, par value NIS 0.0000769 per share | P | 9500 | $0.99 | Acquired | 35115 | Direct |
More from Entera Bio Ltd.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 9